Technology

ThermoGenesis

$2.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.35 (-11.51%) Today
-$0.13 (-4.83%) As of 11:14 AM UTC after-hours

Why Robinhood?

You can buy or sell ThermoGenesis and other stocks, options, and ETFs commission-free!

About THMO

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA. The listed name for THMO is ThermoGenesis Holdings, Inc. Common Stock.

CEO
Xiao Chun Xu
Employees
50
Headquarters
Rancho Cordova, California
Founded
1986
Market Cap
19.32M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.97M
High Today
$3.03
Low Today
$2.62
Open Price
$2.84
Volume
2.12M
52 Week High
$14.18
52 Week Low
$1.63

Collections

THMO Earnings

-$1.36
-$0.89
-$0.42
$0.05
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 23, After Hours

You May Also Like

RMD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure